APA (7th ed.) Citation

GR, M., M, A., A, B., L, W., W, S., J, B., . . . A, K. (2020). Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: A Meta-analysis and systematic review. BMC cancer, 20(1), 507. https://doi.org/10.1186/s12885-020-06948-5

Chicago Style (17th ed.) Citation

GR, Mohyuddin, Aziz M, Britt A, Wade L, Sun W, Baranda J, Al-Rajabi R, Saeed A, and Kasi A. "Similar Response Rates and Survival with PARP Inhibitors for Patients with Solid Tumors Harboring Somatic Versus Germline BRCA Mutations: A Meta-analysis and Systematic Review." BMC Cancer 20, no. 1 (2020): 507. https://doi.org/10.1186/s12885-020-06948-5.

MLA (9th ed.) Citation

GR, Mohyuddin, et al. "Similar Response Rates and Survival with PARP Inhibitors for Patients with Solid Tumors Harboring Somatic Versus Germline BRCA Mutations: A Meta-analysis and Systematic Review." BMC Cancer, vol. 20, no. 1, 2020, p. 507, https://doi.org/10.1186/s12885-020-06948-5.